Family Practice Associates, Pa - Medicare Primary Care in Wilmington, DE

Family Practice Associates, Pa is a medicare enrolled primary clinic (Family Medicine) in Wilmington, Delaware. The current practice location for Family Practice Associates, Pa is 1100 S Broom St, Wilmington, Delaware. For appointments, you can reach them via phone at (302) 656-5416. The mailing address for Family Practice Associates, Pa is 1100 S Broom St, Wilmington, Delaware and phone number is (302) 656-5416.

Family Practice Associates, Pa is licensed to practice in Delaware (license number 1989015228). The clinic also participates in the medicare program and its NPI number is 1053426692. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (302) 656-5416.

Contact Information

Family Practice Associates, Pa
1100 S Broom St
Wilmington
DE 19805-4585
(302) 656-5416
Not Available

Primary Care Clinic Profile

Full NameFamily Practice Associates, Pa
SpecialityFamily Medicine
Location1100 S Broom St, Wilmington, Delaware
Authorized Official Name and PositionEdward R Sobel (PRESIDENT)
Authorized Official Contact3026565416
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Family Practice Associates, Pa
1100 S Broom St
Wilmington
DE 19805-4585

Ph: (302) 656-5416
Family Practice Associates, Pa
1100 S Broom St
Wilmington
DE 19805-4585

Ph: (302) 656-5416

NPI Details:

NPI Number1053426692
Provider Enumeration Date08/21/2006
Last Update Date08/22/2020

Medicare PECOS Information:

Medicare PECOS PAC ID7012985641
Medicare Enrollment IDO20040922000188

News Archive

RPCI studies potential of CellSearch test for monitoring treatment results in metastatic gallbladder patients

Renuka Iyer, MD, of the Department of Medicine, and Dan Iancu, MD, of the Department of Pathology and Laboratory Medicine at Roswell Park Cancer Institute (RPCI) are studying how a new test called CellSearch could be used with standard radiographic methods to monitor treatment results in patients with locally advanced or metastatic gallbladder or biliary duct cancers. The goal of the study is to see if CellSearch could predict patient response to therapy earlier than traditional measures.

New insight into coronary artery disease

Insight into the complex biological mechanisms that cause heart disease has taken a major step forward with the discovery of 13 new genes that increase the risk of coronary artery disease.

Derma Sciences announces pricing of public offering of 972,000 shares of its common stock

Derma Sciences, Inc., a specialty medical device and pharmaceutical company focused on advanced wound care, today announced the pricing of a public offering of 972,000 shares of DSCI common stock and 324,000 warrants to purchase shares of common stock at a price of $5.50.

New and simple urine test detects common cause of kidney transplant failure

A new and simple urine test can detect polyomavirus nephropathy, a relatively new and serious complication that affects up to 9% of kidney transplant recipients, according to a study appearing in the February 2009 issue of the Journal of the American Society Nephrology (JASN).

Subtype of CD4-positive immune cells in the gut may influence HIV infection outcome

The findings of a new study in monkeys may help clarify why some people infected with HIV are better able to control the virus. They also may pinpoint a target for treatment during early HIV infection aimed at increasing the supply of certain immune cells in the gut, which the study shows could be an important factor in limiting HIV growth in cells throughout the body.

Read more Medical News

› Verified 7 days ago

Medical Identifiers

Medical identifiers for Family Practice Associates, Pa such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1053426692NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 1989015228 (Delaware)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Family Practice Associates, Pa acts as a billing entity for following providers:
Provider NameJosefina S Cancino
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1154404143
PECOS PAC ID: 3779483516
Enrollment ID: I20040109000472

News Archive

RPCI studies potential of CellSearch test for monitoring treatment results in metastatic gallbladder patients

Renuka Iyer, MD, of the Department of Medicine, and Dan Iancu, MD, of the Department of Pathology and Laboratory Medicine at Roswell Park Cancer Institute (RPCI) are studying how a new test called CellSearch could be used with standard radiographic methods to monitor treatment results in patients with locally advanced or metastatic gallbladder or biliary duct cancers. The goal of the study is to see if CellSearch could predict patient response to therapy earlier than traditional measures.

New insight into coronary artery disease

Insight into the complex biological mechanisms that cause heart disease has taken a major step forward with the discovery of 13 new genes that increase the risk of coronary artery disease.

Derma Sciences announces pricing of public offering of 972,000 shares of its common stock

Derma Sciences, Inc., a specialty medical device and pharmaceutical company focused on advanced wound care, today announced the pricing of a public offering of 972,000 shares of DSCI common stock and 324,000 warrants to purchase shares of common stock at a price of $5.50.

New and simple urine test detects common cause of kidney transplant failure

A new and simple urine test can detect polyomavirus nephropathy, a relatively new and serious complication that affects up to 9% of kidney transplant recipients, according to a study appearing in the February 2009 issue of the Journal of the American Society Nephrology (JASN).

Subtype of CD4-positive immune cells in the gut may influence HIV infection outcome

The findings of a new study in monkeys may help clarify why some people infected with HIV are better able to control the virus. They also may pinpoint a target for treatment during early HIV infection aimed at increasing the supply of certain immune cells in the gut, which the study shows could be an important factor in limiting HIV growth in cells throughout the body.

Read more Medical News

› Verified 7 days ago

Provider NameJerry P Gluckman
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1629070370
PECOS PAC ID: 6204838733
Enrollment ID: I20070212000603

News Archive

RPCI studies potential of CellSearch test for monitoring treatment results in metastatic gallbladder patients

Renuka Iyer, MD, of the Department of Medicine, and Dan Iancu, MD, of the Department of Pathology and Laboratory Medicine at Roswell Park Cancer Institute (RPCI) are studying how a new test called CellSearch could be used with standard radiographic methods to monitor treatment results in patients with locally advanced or metastatic gallbladder or biliary duct cancers. The goal of the study is to see if CellSearch could predict patient response to therapy earlier than traditional measures.

New insight into coronary artery disease

Insight into the complex biological mechanisms that cause heart disease has taken a major step forward with the discovery of 13 new genes that increase the risk of coronary artery disease.

Derma Sciences announces pricing of public offering of 972,000 shares of its common stock

Derma Sciences, Inc., a specialty medical device and pharmaceutical company focused on advanced wound care, today announced the pricing of a public offering of 972,000 shares of DSCI common stock and 324,000 warrants to purchase shares of common stock at a price of $5.50.

New and simple urine test detects common cause of kidney transplant failure

A new and simple urine test can detect polyomavirus nephropathy, a relatively new and serious complication that affects up to 9% of kidney transplant recipients, according to a study appearing in the February 2009 issue of the Journal of the American Society Nephrology (JASN).

Subtype of CD4-positive immune cells in the gut may influence HIV infection outcome

The findings of a new study in monkeys may help clarify why some people infected with HIV are better able to control the virus. They also may pinpoint a target for treatment during early HIV infection aimed at increasing the supply of certain immune cells in the gut, which the study shows could be an important factor in limiting HIV growth in cells throughout the body.

Read more Medical News

› Verified 7 days ago

Provider NameDavid M Krasner
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1629017447
PECOS PAC ID: 8325127277
Enrollment ID: I20101230000145

News Archive

RPCI studies potential of CellSearch test for monitoring treatment results in metastatic gallbladder patients

Renuka Iyer, MD, of the Department of Medicine, and Dan Iancu, MD, of the Department of Pathology and Laboratory Medicine at Roswell Park Cancer Institute (RPCI) are studying how a new test called CellSearch could be used with standard radiographic methods to monitor treatment results in patients with locally advanced or metastatic gallbladder or biliary duct cancers. The goal of the study is to see if CellSearch could predict patient response to therapy earlier than traditional measures.

New insight into coronary artery disease

Insight into the complex biological mechanisms that cause heart disease has taken a major step forward with the discovery of 13 new genes that increase the risk of coronary artery disease.

Derma Sciences announces pricing of public offering of 972,000 shares of its common stock

Derma Sciences, Inc., a specialty medical device and pharmaceutical company focused on advanced wound care, today announced the pricing of a public offering of 972,000 shares of DSCI common stock and 324,000 warrants to purchase shares of common stock at a price of $5.50.

New and simple urine test detects common cause of kidney transplant failure

A new and simple urine test can detect polyomavirus nephropathy, a relatively new and serious complication that affects up to 9% of kidney transplant recipients, according to a study appearing in the February 2009 issue of the Journal of the American Society Nephrology (JASN).

Subtype of CD4-positive immune cells in the gut may influence HIV infection outcome

The findings of a new study in monkeys may help clarify why some people infected with HIV are better able to control the virus. They also may pinpoint a target for treatment during early HIV infection aimed at increasing the supply of certain immune cells in the gut, which the study shows could be an important factor in limiting HIV growth in cells throughout the body.

Read more Medical News

› Verified 7 days ago

Provider NameLindsay H Kelly
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1265815526
PECOS PAC ID: 8022322981
Enrollment ID: I20150810001853

News Archive

RPCI studies potential of CellSearch test for monitoring treatment results in metastatic gallbladder patients

Renuka Iyer, MD, of the Department of Medicine, and Dan Iancu, MD, of the Department of Pathology and Laboratory Medicine at Roswell Park Cancer Institute (RPCI) are studying how a new test called CellSearch could be used with standard radiographic methods to monitor treatment results in patients with locally advanced or metastatic gallbladder or biliary duct cancers. The goal of the study is to see if CellSearch could predict patient response to therapy earlier than traditional measures.

New insight into coronary artery disease

Insight into the complex biological mechanisms that cause heart disease has taken a major step forward with the discovery of 13 new genes that increase the risk of coronary artery disease.

Derma Sciences announces pricing of public offering of 972,000 shares of its common stock

Derma Sciences, Inc., a specialty medical device and pharmaceutical company focused on advanced wound care, today announced the pricing of a public offering of 972,000 shares of DSCI common stock and 324,000 warrants to purchase shares of common stock at a price of $5.50.

New and simple urine test detects common cause of kidney transplant failure

A new and simple urine test can detect polyomavirus nephropathy, a relatively new and serious complication that affects up to 9% of kidney transplant recipients, according to a study appearing in the February 2009 issue of the Journal of the American Society Nephrology (JASN).

Subtype of CD4-positive immune cells in the gut may influence HIV infection outcome

The findings of a new study in monkeys may help clarify why some people infected with HIV are better able to control the virus. They also may pinpoint a target for treatment during early HIV infection aimed at increasing the supply of certain immune cells in the gut, which the study shows could be an important factor in limiting HIV growth in cells throughout the body.

Read more Medical News

› Verified 7 days ago

Provider NameLeila M Gaines
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1861596405
PECOS PAC ID: 0547310997
Enrollment ID: I20220105000492

News Archive

RPCI studies potential of CellSearch test for monitoring treatment results in metastatic gallbladder patients

Renuka Iyer, MD, of the Department of Medicine, and Dan Iancu, MD, of the Department of Pathology and Laboratory Medicine at Roswell Park Cancer Institute (RPCI) are studying how a new test called CellSearch could be used with standard radiographic methods to monitor treatment results in patients with locally advanced or metastatic gallbladder or biliary duct cancers. The goal of the study is to see if CellSearch could predict patient response to therapy earlier than traditional measures.

New insight into coronary artery disease

Insight into the complex biological mechanisms that cause heart disease has taken a major step forward with the discovery of 13 new genes that increase the risk of coronary artery disease.

Derma Sciences announces pricing of public offering of 972,000 shares of its common stock

Derma Sciences, Inc., a specialty medical device and pharmaceutical company focused on advanced wound care, today announced the pricing of a public offering of 972,000 shares of DSCI common stock and 324,000 warrants to purchase shares of common stock at a price of $5.50.

New and simple urine test detects common cause of kidney transplant failure

A new and simple urine test can detect polyomavirus nephropathy, a relatively new and serious complication that affects up to 9% of kidney transplant recipients, according to a study appearing in the February 2009 issue of the Journal of the American Society Nephrology (JASN).

Subtype of CD4-positive immune cells in the gut may influence HIV infection outcome

The findings of a new study in monkeys may help clarify why some people infected with HIV are better able to control the virus. They also may pinpoint a target for treatment during early HIV infection aimed at increasing the supply of certain immune cells in the gut, which the study shows could be an important factor in limiting HIV growth in cells throughout the body.

Read more Medical News

› Verified 7 days ago

Provider NameMatthew Roman
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1558649061
PECOS PAC ID: 1456578111
Enrollment ID: I20240127000474

News Archive

RPCI studies potential of CellSearch test for monitoring treatment results in metastatic gallbladder patients

Renuka Iyer, MD, of the Department of Medicine, and Dan Iancu, MD, of the Department of Pathology and Laboratory Medicine at Roswell Park Cancer Institute (RPCI) are studying how a new test called CellSearch could be used with standard radiographic methods to monitor treatment results in patients with locally advanced or metastatic gallbladder or biliary duct cancers. The goal of the study is to see if CellSearch could predict patient response to therapy earlier than traditional measures.

New insight into coronary artery disease

Insight into the complex biological mechanisms that cause heart disease has taken a major step forward with the discovery of 13 new genes that increase the risk of coronary artery disease.

Derma Sciences announces pricing of public offering of 972,000 shares of its common stock

Derma Sciences, Inc., a specialty medical device and pharmaceutical company focused on advanced wound care, today announced the pricing of a public offering of 972,000 shares of DSCI common stock and 324,000 warrants to purchase shares of common stock at a price of $5.50.

New and simple urine test detects common cause of kidney transplant failure

A new and simple urine test can detect polyomavirus nephropathy, a relatively new and serious complication that affects up to 9% of kidney transplant recipients, according to a study appearing in the February 2009 issue of the Journal of the American Society Nephrology (JASN).

Subtype of CD4-positive immune cells in the gut may influence HIV infection outcome

The findings of a new study in monkeys may help clarify why some people infected with HIV are better able to control the virus. They also may pinpoint a target for treatment during early HIV infection aimed at increasing the supply of certain immune cells in the gut, which the study shows could be an important factor in limiting HIV growth in cells throughout the body.

Read more Medical News

› Verified 7 days ago

News Archive

RPCI studies potential of CellSearch test for monitoring treatment results in metastatic gallbladder patients

Renuka Iyer, MD, of the Department of Medicine, and Dan Iancu, MD, of the Department of Pathology and Laboratory Medicine at Roswell Park Cancer Institute (RPCI) are studying how a new test called CellSearch could be used with standard radiographic methods to monitor treatment results in patients with locally advanced or metastatic gallbladder or biliary duct cancers. The goal of the study is to see if CellSearch could predict patient response to therapy earlier than traditional measures.

New insight into coronary artery disease

Insight into the complex biological mechanisms that cause heart disease has taken a major step forward with the discovery of 13 new genes that increase the risk of coronary artery disease.

Derma Sciences announces pricing of public offering of 972,000 shares of its common stock

Derma Sciences, Inc., a specialty medical device and pharmaceutical company focused on advanced wound care, today announced the pricing of a public offering of 972,000 shares of DSCI common stock and 324,000 warrants to purchase shares of common stock at a price of $5.50.

New and simple urine test detects common cause of kidney transplant failure

A new and simple urine test can detect polyomavirus nephropathy, a relatively new and serious complication that affects up to 9% of kidney transplant recipients, according to a study appearing in the February 2009 issue of the Journal of the American Society Nephrology (JASN).

Subtype of CD4-positive immune cells in the gut may influence HIV infection outcome

The findings of a new study in monkeys may help clarify why some people infected with HIV are better able to control the virus. They also may pinpoint a target for treatment during early HIV infection aimed at increasing the supply of certain immune cells in the gut, which the study shows could be an important factor in limiting HIV growth in cells throughout the body.

Read more News

› Verified 7 days ago


Family Medicine in Wilmington, DE

Lindo Family Health & Wellness Care
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 5309 Limestone Rd B, Wilmington, DE 19808
Phone: 302-604-3448    
Seth D Torregiani Do, Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 1 Righter Pkwy Ste 150, Wilmington, DE 19803
Phone: 302-559-0641    Fax: 302-406-2668
Cchs Sports Medicine
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3506 Kennett Pike, Wilmington, DE 19807
Phone: 302-661-3000    Fax: 302-661-3470
Caring Minds Medical Center Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 5235 W Woodmill Dr, Suite 46, Wilmington, DE 19808
Phone: 267-243-9102    Fax: 215-743-0717
Life Health @ Bayard
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 200 S Dupont St, Wilmington, DE 19805
Phone: 302-407-5316    Fax: 302-407-5307
Rediclinic Of De, Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1718 Marsh Rd, Wilmington, DE 19810
Phone: 713-335-1754    Fax: 713-358-4870
First State Medical Pa
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3521 Silverside Rd, Quillen Building Suite 2d1, Wilmington, DE 19810
Phone: 302-479-0555    Fax: 302-479-5006

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.